R.E.A. (RE) Competitors GBX 98 +2.25 (+2.35%) As of 08/22/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock RE vs. CAM, PAL, DKL, AAAP, EVST, AGTA, PIL, MPE, TOT, and AEPShould you be buying R.E.A. stock or one of its competitors? The main competitors of R.E.A. include Camellia (CAM), Equatorial Palm Oil plc (PAL.L) (PAL), Dekel Agri-Vision (DKL), Anglo African Agriculture (AAAP), Everest Global (EVST), Agriterra (AGTA), Produce Investments (PIL), M.P. Evans Group (MPE), Total Produce (TOT), and Anglo-Eastern Plantations (AEP). These companies are all part of the "farm products" industry. R.E.A. vs. Its Competitors Camellia Equatorial Palm Oil plc (PAL.L) Dekel Agri-Vision Anglo African Agriculture Everest Global Agriterra Produce Investments M.P. Evans Group Total Produce Anglo-Eastern Plantations Camellia (LON:CAM) and R.E.A. (LON:RE) are both small-cap consumer defensive companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment. Is CAM or RE a better dividend stock? Camellia pays an annual dividend of GBX 146 per share and has a dividend yield of 2.5%. R.E.A. pays an annual dividend of GBX 8 per share and has a dividend yield of 8.2%. Camellia pays out -19.9% of its earnings in the form of a dividend. R.E.A. pays out 133.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Do insiders & institutionals hold more shares of CAM or RE? 9.1% of Camellia shares are owned by institutional investors. Comparatively, 43.4% of R.E.A. shares are owned by institutional investors. 69.5% of Camellia shares are owned by company insiders. Comparatively, 41.4% of R.E.A. shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is CAM or RE more profitable? R.E.A. has a net margin of 1.05% compared to Camellia's net margin of -7.61%. R.E.A.'s return on equity of 0.91% beat Camellia's return on equity.Company Net Margins Return on Equity Return on Assets Camellia-7.61% -6.30% -1.27% R.E.A. 1.05%0.91%2.53% Does the media refer more to CAM or RE? In the previous week, Camellia had 2 more articles in the media than R.E.A.. MarketBeat recorded 3 mentions for Camellia and 1 mentions for R.E.A.. R.E.A.'s average media sentiment score of 0.46 beat Camellia's score of 0.27 indicating that R.E.A. is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Camellia 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral R.E.A. 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better valuation & earnings, CAM or RE? R.E.A. has higher revenue and earnings than Camellia. Camellia is trading at a lower price-to-earnings ratio than R.E.A., indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCamellia£266.06M0.60-£20.24M-£734.97-7.89R.E.A.£387.39M0.14£4.07M£6.0116.32 Which has more volatility & risk, CAM or RE? Camellia has a beta of 0.47, suggesting that its share price is 53% less volatile than the S&P 500. Comparatively, R.E.A. has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. SummaryR.E.A. beats Camellia on 11 of the 15 factors compared between the two stocks. Get R.E.A. News Delivered to You Automatically Sign up to receive the latest news and ratings for RE and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RE vs. The Competition Export to ExcelMetricR.E.A.Farm Products IndustryDefensive SectorLON ExchangeMarket Cap£53.39M£165.16M£7.73B£3.22BDividend Yield3.09%3.00%3.17%5.04%P/E Ratio16.327.2213.50164.70Price / Sales0.1438.171,488.28310,111.41Price / Cash2.629.00144.7427.93Price / Book0.091.1410.095.91Net Income£4.07M£375.04M£999.43M£5.89B7 Day Performance2.62%1.86%234.71%49.53%1 Month Performance11.05%5.43%264.70%56.40%1 Year Performance20.62%24.79%221.47%136.21% R.E.A. Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RER.E.A.N/AGBX 98+2.3%N/A+14.7%£53.39M£387.39M16.329,379News CoverageHigh Trading VolumeCAMCamelliaN/AGBX 5,900+3.5%N/A+27.2%£162.45M£266.06M-8.03104,728News CoverageGap UpPALEquatorial Palm Oil plc (PAL.L)N/AN/AN/AN/A£91.26M£11K-11.763Gap DownDKLDekel Agri-VisionN/AGBX 0.50+5.3%N/A-62.5%£3.26M£42.11M-0.592,020Gap UpHigh Trading VolumeAAAPAnglo African AgricultureN/AN/AN/AN/A£1.03M£1.30M-1.48501EVSTEverest GlobalN/AGBX 0.97+29.3%N/A-71.4%£751K£2.45M-97.0017Gap UpAGTAAgriterraN/AGBX 0.55flatN/A-37.1%£407K£10.39M-18.33402PILProduce InvestmentsN/AN/AN/AN/A£0.00N/A0.00N/AMPEM.P. Evans GroupN/AGBX 1,295-0.8%GBX 1,375+6.2%+52.4%£840.61M£408.94M13.0512,800TOTTotal ProduceN/AN/AN/AN/A£641.85M£3.82B18.755,974AEPAnglo-Eastern PlantationsN/AGBX 1,130-0.9%N/A+102.3%£564.94M£461.13M8.7512,671News CoveragePositive NewsInsider Trade Related Companies and Tools Related Companies CAM Alternatives PAL Alternatives DKL Alternatives AAAP Alternatives EVST Alternatives AGTA Alternatives PIL Alternatives MPE Alternatives TOT Alternatives AEP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:RE) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding R.E.A. Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share R.E.A. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.